MORGAN STANLEY

Holdings History for Aldeyra Therapeutics, Inc. - COM (ALDX)

Symbol: ALDX on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$2.81M	521K	+209,242	+67.2%	$5.39	Q3 2024
6/30/2024			$4.00	1			$4.00^*	Q2 2024
6/30/2024	0%	0%	$1.03M	311K	-38,142	-10.9%	$3.31	Q2 2024
3/31/2024	0%	0%	$1.14M	350K	-70,522	-16.8%	$3.27	Q1 2024
12/31/2023	0%	+0%	$1.47M	420K	+170,953	+68.6%	$3.51	Q4 2023
9/30/2023	0%	0%	$1.66M	249K	-71,913	-22.4%	$6.68	Q3 2023
6/30/2023	0%	0%	$2.69M	321K	-858,935	-72.8%	$8.39	Q2 2023
3/31/2023	0%	+0%	$11.7M	1.18M	+864,713	+274%	$9.93	Q1 2023
12/31/2022	0%	+0%	$2.19M	315K	+12,686	+4.19%	$6.96	Q4 2022
9/30/2022	0%	0%	$1.62M	303K	-61,952	-17%	$5.34	Q3 2022
6/30/2022			$1K	370			$2.70^*	Q2 2022
6/30/2022	0%	+0%	$1.45M	365K	+11,366	+3.22%	$3.99	Q2 2022
3/31/2022	0%	+0%	$1.57M	353K	+180,461	+105%	$4.45	Q1 2022
12/31/2021			$2K	403			$4.96^*	Q4 2021
12/31/2021	0%	+0%	$691K	173K	+117,619	+214%	$4.00	Q4 2021
9/30/2021	0%	0%	$483K	55.1K	-36,677	-40%	$8.77	Q3 2021
6/30/2021	0%	+0%	$1.04M	91.7K	+75,372	+460%	$11.34	Q2 2021
3/31/2021	0%	+0%	$194K	16.4K	+3,680	+29%	$11.85	Q1 2021
12/31/2020	0%	+0%	$87K	12.7K	+7,295	+135%	$6.85	Q4 2020
9/30/2020	0%	0%	$40K	5.4K	-212,366	-97.5%	$7.41	Q3 2020
6/30/2020	0%	+0%	$908K	218K	+215,979	+12086%	$4.17	Q2 2020
3/31/2020	0%	0%	$4K	1.79K	-31,089	-94.6%	$2.24	Q1 2020
12/31/2019	0%	+0%	$191K	32.9K	+23,493	+250%	$5.81	Q4 2019
9/30/2019	0%	+0%	$50K	9.38K	+7,383	+369%	$5.33	Q3 2019
6/30/2019			$2K	269			$7.43^*	Q2 2019
6/30/2019	0%	0%	$12K	2K	-3,839	-65.7%	$6.00	Q2 2019
3/31/2019	0%	0%	$53K	5.84K	-27,778	-82.6%	$9.08	Q1 2019
12/31/2018	0%	0%	$279K	33.6K	-2,609	-7.2%	$8.30	Q4 2018
9/30/2018	0%	0%	$500K	36.2K	-6,546	-15.3%	$13.80	Q3 2018
6/30/2018	0%	+0%	$340K	42.8K	+27,976	+189%	$7.95	Q2 2018
3/31/2018	0%	+0%	$111K	14.8K	+4,686	+46.4%	$7.50	Q1 2018
12/31/2017	0%	+0%	$69K	10.1K	+427	+4.41%	$6.82	Q4 2017
9/30/2017			$1K	100			$10.00^*	Q3 2017
9/30/2017	0%	+0%	$70K	9.68K	+6,890	+247%	$7.23	Q3 2017
6/30/2017	0%		$13K	2.79K			$4.65	Q2 2017
3/31/2017	0%		$14K	2.79K	-189	-6.34%	$5.01	Q1 2017
12/31/2016	0%	0%	$16K	2.98K	-1,478	-33.1%	$5.37	Q4 2016
9/30/2016	0%	+0%	$35K	4.46K	+573	+14.7%	$7.85	Q3 2016
6/30/2016	0%	+0%	$22K	3.89K	+298	+8.3%	$5.66	Q2 2016
3/31/2016	0%	0%	$15K	3.59K	-3,633	-50.3%	$4.18	Q1 2016
12/31/2015	0%	0%	$49K	7.22K	-13,274	-64.8%	$6.78	Q4 2015
9/30/2015	0%	+0%	$119K	20.5K	+3,992	+24.2%	$5.81	Q3 2015
6/30/2015	0%	+0%	$128K	16.5K	+2,663	+19.2%	$7.76	Q2 2015
3/31/2015	0%	+0%	$141K	13.8K	+12,550	+972%	$10.19	Q1 2015
12/31/2014	0%	+0%	$9K	1.29K	+1,291	NEW	$6.97	Q4 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.